Company intelligence / Profile preview
Ipsen
Boulogne-Billancourt, Franceipsen.com ↗
- Ownership
- Public · IPN
- Employees
- ~5350
- Development stage
- Other
01
Overview
Ipsen has a robust commercial portfolio in oncology (e.g., Somatuline for NETs; Decapeptyl for hormone-dependent conditions/cancers; Tazverik for follicular lymphoma) and rare diseases. Recent clinical results include positive data for elafibranor in primary sclerosing cholangitis and Bylvay in severe itch associated with pediatric liver disease. The company continues to expand its pipeline via internal R&D and acquisitions/licensing deals
- Therapeutic areas
- OncologyRare DiseasesNeurology
- Modalities
- Small moleculesbiologics (including recombinant neurotoxins)antibody drug conjugatesT-cell engagers
- Industry
- Biotech
02
Drug pipeline
86 assets85 more assets in the full pipeline.
03
Partnerships
Galderma (aesthetic botulinum toxins)Biomunex Pharmaceuticals (BMX‑502 licensing deal)Various academic collaborations globally [7]
04
Financials
- Market cap
- $14.4B
- Total revenue
- $4.1B
- Enterprise value
- $13.3B
Beyond the preview
Go deeper on Ipsen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ipsen.